ComplianceOnline

Foreign materials found in Rolaids® Extra Strength Softchews, Roldaids® Extra Strength Plus Gas Soft-chews, and Roldaids® Multi-Symptom Plus Anti-Gas Softchews: McNeil recalls all Lots Voluntarily

  • Date: December 28, 2010
  • Source: Admin
Webinar All Access Pass Subscription Abstract:

McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., has voluntarily recalled all lots of ROLAIDS® Extra Strength Softchews, ROLAIDS® Extra Strength plus Gas Softchews, and ROLAIDS® Multi-Symptom plus Anti-Gas Softchews distributed in the United States. The recall was issued after the presence of foreign materials in the product, including metal and wood particles, was reported. The company’s investigations have led it to conclude that the materials possibly found their way into the product during its manufacture at a third party facility. The FDA has since suspended production of ROLAIDS® Extra Strength Softchews, ROLAIDS® Extra Strength plus Gas Softchews, and ROLAIDS® Multi-Symptom plus Anti-Gas Softchews even as its own investigations into the matter continue. Production will resume once corrective actions are implemented. This recall was conducted with the knowledge of the U.S. Food and Drug Administration (FDA).

Although the risk of serious adverse health consequences is remote, McNeil Consumer Healthcare has advised consumers not to use the product by way of abundant caution. In particular, consumers who have medical concerns or questions should contact their healthcare provider.

Regulations

The Prescription Drug Marketing Act (PDMA) of 1987 (P.L. 100-293, 102 Stat. 95) is a law of the United States federal government. The U.S. Food and Drug Administration (FDA) issued regulations implementing the PDMA in 1990 (21 C.F.R. Part 205) and 1999 (21 C.F.R. Part 203). It establishes legal safeguards for prescription drug distribution to ensure safe and effective pharmaceuticals. It is designed to discourage the sale of counterfeit, adulterated, misbranded, sub-potent, and expired prescription drugs. The agency can pursue action through the Department of Justice in the federal court system to remove adulterated and misbranded drugs from the market.

Source:  

http://www.fda.gov/Safety/Recalls/ucm236715.htm

http://en.wikipedia.org/wiki/Food_and_Drug_Administration

 

Bookmark and Share

Trending Compliance Trainings

HVAC and GMP Environmental Control - for Pharmaceutical Cleanrooms
By - Roger Cowan
On Demand Access Anytime
Extractables and Leachables in Early Phase Development
By - Wayland Rushing
On Demand Access Anytime
CGMP controlled Raw Materials
By - Charity Ogunsanya
On Demand Access Anytime
OTC Drug Regulations
By - Loren Gelber
On Demand Access Anytime
Veterinary Feed Directive (VFD) Final Rule - What you need to know
By - Bernadette Alisantosa
On Demand Access Anytime
Best Sellers
You Recently Viewed
    Loading